CAS: 1380723-44-3 - Atezolizumab
Formula:Unspecified
- Synonyms:
- Immunoglobulin G1, anti-(human programmed death-1 ligand-1) (human monoclonal MPDL3280A heavy chain), disulfide with human monoclonal MPDL3280A κ-chain, dimer
- Atezolizumab
- Immunoglobulin G1, anti-(human CD antigen CD274) (human monoclonal MPDL3280A heavy chain), disulfide with human monoclonal MPDL3280A κ-chain, dimer
- MPDL 3280A
- RG 7446
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Atezolizumab REF: IN-DA01E6NDCAS: 1380723-44-3 | 98% | To inquire | Tue 07 Jan 25 |
 | Atezolizumab REF: TM-T9902CAS: 1380723-44-3 | 95.10% - 95.20% | 213.00 €~741.00 € | Tue 14 Jan 25 |
 | Atezolizumab REF: 3D-BA165584CAS: 1380723-44-3 | Min. 95% | 897.00 € | Tue 21 Jan 25 |
Ref: IN-DA01E6ND
| 1mg | 122.00 € | ||
| 100mg | To inquire |
Estimated delivery in United States, on Tuesday 7 Jan 2025
Atezolizumab
CAS:1380723-44-3
Atezolizumab is an antibody inhibitor, a humanized monoclonal antibody, IgG1, which targets PD-L1. Atezolizumab has …
Purity:
95.10% - 95.20%
Color and Shape:
Liquid
Molecular weight:
145 kDa
Ref: TM-T9902
| 1mg | 213.00 € | ||
| 5mg | 505.00 € | ||
| 10mg | 741.00 € |
Estimated delivery in United States, on Tuesday 14 Jan 2025
Atezolizumab
CAS:1380723-44-3
Monoclonal antibody against PDL-1; anti-cancer agent
Purity:
Min. 95%
Color and Shape:
Clear Liquid
Ref: 3D-BA165584
| 1mg | 897.00 € |
Estimated delivery in United States, on Tuesday 21 Jan 2025
